Literature DB >> 29669507

Buxus sempervirens L. Improves Lipid Profile in Diabetic Rats.

Mohammed Ajebli1, Mohamed Eddouks1.   

Abstract

INTRODUCTION: Buxus sempervirens L. is used in Morocco as a plant with some medicinal properties including treatment of diabetes and cardiovascular diseases.
METHODS: The objective of the study was to assess the effect of the aqueous extract of Buxus sempervirens L. (Boxwood) leaves on the blood lipid parameters including total cholesterol, triglycerides, High-Density Lipoprotein Cholesterol (HDL-C), Low-Density Lipoprotein Cholesterol (LDL-C) and Very Low-Density Lipoprotein Cholesterol (VLDL-C) in normal and streptozotocininduced diabetic rats. In addition, antioxidant activity of aqueous Buxus sempervirens extract was evaluated by DPPH and FRAP assays.
RESULTS: The results indicated a significant decrease in serum total cholesterol and LDL-C levels, while, no change was observed on triglycerides and VLDL-C values in diabetic rats. Lipid profile of normal animals did not reveal any modification. In addition the aqueous extract of Buxus sempervirens exerted a significant antioxidant activity. Therefore, the results suggest that the aqueous extract of Buxus sempervirens exhibits lipid lowering activity which could be due partially to its antioxidant ability.
CONCLUSION: In conclusion, Buxus sempervirens leaf extract may be helpful in controlling the development of hyperlipidemia as well as atherosclerosis in diabetic animals. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Buxus sempervirens L.; antioxidant; atherosclerosis; diabetic; hyperlipidemia; lipid profile.

Mesh:

Substances:

Year:  2018        PMID: 29669507     DOI: 10.2174/1871529X18666180419100823

Source DB:  PubMed          Journal:  Cardiovasc Hematol Disord Drug Targets        ISSN: 1871-529X


  1 in total

1.  Flavonoid-Enriched Extract from Desert Plant Warionia saharae Improves Glucose and Cholesterol Levels in Diabetic Rats.

Authors:  Mohammed Ajebli; Mohamed Eddouks
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2019
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.